Stanford University
Showing 1,091-1,100 of 2,070 Results
-
John Higgins
Adjunct Professor, Materials Science and Engineering
BioJohn received a BS in biochemistry from Albright College and his Ph.D. in synthetic organic chemistry from Brown University. After completing a Postdoctoral Fellowship at the Sloan-Kettering Cancer Institute in NYC in the departments of Positron Emission Tomography and Neurology, he joined the Medicinal Chemistry Discovery group at Johnson Matthey Biomedical. There he made several significant contributions to early research projects on new Pt- antitumor drugs and peptide-based diagnostic radio-imaging agents. After nearly a decade as a discovery med chemist, he moved on to drug development in positions of increasing responsibility at J&J and Sanofi-Aventis. He and his teams have specialized in the areas of drug delivery, solid state chemistry and biomaterials in relation to improving the bioperformance of therapeutic agents. Towards this end, he has led the successful implementation of a wide range of methodologies into drug discovery space including prodrug design for enhanced solubility/permeability, miniaturized polymeric amorphous dispersions and nanoparticle technologies.
John currently is Executive Director of the Discovery Pharmaceutical Sciences department at Merck’s Discovery Center. In this multidisciplinary role, he is responsible for oversight of the biopharmaceutical and drug delivery aspects of Merck’s discovery programs (small molecules and peptides) as well as the identification of new enabling technologies. Over his over 30 year pharma career, he is co-inventor on 13 US Patents and author of numerous and diverse publications and book chapters in the fields of organic, solid state & medicinal chemistry and drug delivery.
John also currently serves as an Adjunct Associate Professor at the University of Pennsylvania School of Medicine, where he regularly teaches classes in various aspects of drug discovery and development. -
John Higgins
Professor of Pathology
Current Research and Scholarly InterestsI work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.
-
Georgios E. Hilaris
Adjunct Clinical Instructor, Obstetrics & Gynecology - Gynecologic Oncology
BioGeorgios "George" Hilaris MD is a Gynecologic Oncology and Minimally-invasive Gynecologic Surgery Specialist.
He received his residency training at the UCLA David Geffen School of Medicine, in Los Angeles California and RUSH University Medical Center of RUSH Medical College in Chicago, Illinois. He completed his fellowship training at Stanford University in Palo Alto California.
In his home country Greece, he is considered an innovator in Gynecologic Oncology and Laparoscopic/Robotic Gynecologic Surgery.
Some of his pioneering work include the first in Greece laparoscopic radical hysterectomy with systematic pelvic and paraaortic lymph node dissection in 2004 as well as first Robotic-assisted surgical staging for endometrial cancer in 2009.
In 2018 he also led the team that described the first in Greece, Robotic-assisted interval cytoreduction for advanced stage ovarian cancer.
He has also published the first series of Laparoscopic staging of early stage cervical and endometrial cancers in Greece in 2008.
He is Adjunct Faculty at Stanford University School of Medicine, since 2007.
Since February 2018, he serves as the Director and Head of the 2nd Department of Gynecologic Oncology in Hygeia Hospital, the largest private medical center, in Athens Greece
